loadpatents
name:-0.05742883682251
name:-0.017247915267944
name:-0.025166034698486
Lannutti; Brian Patent Filings

Lannutti; Brian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lannutti; Brian.The latest application filed is for "anti-ror1 / anti-cd3 bispecific binding molecules".

Company Profile
22.15.52
  • Lannutti; Brian - San Diego CA
  • Lannutti; Brian - Solana Beach CA
  • Lannutti; Brian - Seattle WA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-ror1 / Anti-cd3 Bispecific Binding Molecules
App 20220227866 - Watkins; Jeffry D. ;   et al.
2022-07-21
Cancer Treatment With Ror1 Antibody Immunoconjugates
App 20220152214 - Miller; Langdon ;   et al.
2022-05-19
Ror1 Antibody Immunoconjugates
App 20220133901 - Lannutti; Brian ;   et al.
2022-05-05
Uses of indolinone compounds
Grant 11,285,132 - Lannutti , et al. March 29, 2
2022-03-29
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor
App 20220088013 - Hamdy; Ahmed ;   et al.
2022-03-24
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
App 20210346382 - Hamdy; Ahmed ;   et al.
2021-11-11
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor
Grant 11,166,951 - Hamdy , et al. November 9, 2
2021-11-09
Therapeutic combinations of a MEK inhibitor and a BTK inhibitor
Grant 11,154,554 - Rothbaum , et al. October 26, 2
2021-10-26
Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate
App 20210322408 - Lannutti; Brian ;   et al.
2021-10-21
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
Grant 11,090,302 - Hamdy , et al. August 17, 2
2021-08-17
Uses Of Indolinone Compounds
App 20200253927 - Kind Code
2020-08-13
Uses of indolinone compounds
Grant 10,646,470 - Lannutti , et al.
2020-05-12
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
App 20200069668 - Lannutti; Brian ;   et al.
2020-03-05
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor
App 20200069796 - Hamdy; Ahmed ;   et al.
2020-03-05
ROR1 Antibody Immunoconjugates
App 20200030454 - Lannutti; Brian ;   et al.
2020-01-30
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
App 20190381044 - Hamdy; Ahmed ;   et al.
2019-12-19
Therapeutic Combinations of an Antifolate and a BTK Inhibitor
App 20190374543 - Kaptein; Allard ;   et al.
2019-12-12
Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
App 20190374539 - Rothbaum; Wayne ;   et al.
2019-12-12
Therapeutic Combination of a PI3K Inhibitor and a BTK Inhibitor
App 20190358235 - HAMDY; Ahmed ;   et al.
2019-11-28
Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesi
App 20190314369 - Lannutti; Brian ;   et al.
2019-10-17
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor
App 20190290644 - Hamdy; Ahmed ;   et al.
2019-09-26
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
App 20190209591 - Lannutti; Brian ;   et al.
2019-07-11
ROR1 antibody immunoconjugates
Grant 10,335,496 - Lannutti , et al.
2019-07-02
Therapeutic combination of PI3K inhibitor and a BTK inhibitor
Grant 10,328,080 - Hamdy , et al.
2019-06-25
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
Grant 10,272,083 - Hamdy , et al.
2019-04-30
Therapies For Hematologic Malignancies
App 20190083498 - GALLATIN; W. Michael ;   et al.
2019-03-21
Therapeutic Combinations of a BTK Inhibitor and a GITR Binding Molecule, a 4-1BB Agonist, or an OX40 Agonist
App 20190022092 - Rothbaum; Wayne ;   et al.
2019-01-24
Uses Of Indolinone Compounds
App 20190022062 - Lannutti; Brian ;   et al.
2019-01-24
Therapeutic Combinations of an Antifolate and a BTK Inhibitor
App 20190008869 - Kaptein; Allard ;   et al.
2019-01-10
Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
App 20190008859 - Rothbaum; Wayne ;   et al.
2019-01-10
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
App 20180369244 - Hamdy; Ahmed ;   et al.
2018-12-27
ROR1 Antibody Immunoconjugates
App 20180369406 - Lannutti; Brian ;   et al.
2018-12-27
Uses of indolinone compounds
Grant 10,159,660 - Lannutti , et al. Dec
2018-12-25
Therapies for hematologic malignancies
Grant 10,154,998 - Gallatin , et al. Dec
2018-12-18
Therapeutic Combinations of a CD19 Inhibitor and a BTK Inhibitor
App 20180317602 - Rothbaum; Wayne ;   et al.
2018-11-08
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor
App 20180250298 - Hamdy; Ahmed ;   et al.
2018-09-06
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK4/6 Inhibitor
App 20180250400 - Hamdy; Ahmed ;   et al.
2018-09-06
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor
App 20180207154 - Hamdy; Ahmed ;   et al.
2018-07-26
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor
Grant 9,949,971 - Hamdy , et al. April 24, 2
2018-04-24
Uses Of Indolinone Compounds
App 20180028495 - Lannutti; Brian ;   et al.
2018-02-01
Therapeutic Combination of PI3K Inhibitor and a BTK Inhibitor
App 20170266191 - Hamdy; Ahmed ;   et al.
2017-09-21
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor
App 20170239351 - Hamdy; Ahmed ;   et al.
2017-08-24
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
App 20170231995 - Hamdy; Ahmed ;   et al.
2017-08-17
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor
App 20170231986 - Hamdy; Ahmed ;   et al.
2017-08-17
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK 4/6 Inhibitor
App 20170224819 - Hamdy; Ahmed ;   et al.
2017-08-10
Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate
App 20170143712 - Lannutti; Brian ;   et al.
2017-05-25
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor
App 20170136014 - Hamdy; Ahmed ;   et al.
2017-05-18
Combination Therapies For Hematologic Malignancies
App 20170119771 - GALLATIN; W. Michael ;   et al.
2017-05-04
Therapies For Hematologic Malignancies
App 20170112841 - GALLATIN; W. Michael ;   et al.
2017-04-27
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor
App 20170095471 - Ahmed; Hamdy ;   et al.
2017-04-06
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
App 20170071962 - Lannutti; Brian ;   et al.
2017-03-16
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
App 20170035881 - Lannutti; Brian ;   et al.
2017-02-09
Therapies for hematologic malignancies
Grant 9,492,449 - Gallatin , et al. November 15, 2
2016-11-15
Therapies For Treating Myeloproliferative Disorders
App 20160279135 - Lannutti; Brian ;   et al.
2016-09-29
Combination Therapies For Hematologic Malignancies
App 20150196564 - GALLATIN; W. Michael ;   et al.
2015-07-16
Therapies For Treating Myeloproliferative Disorders
App 20150148345 - Lannutti; Brian ;   et al.
2015-05-28
Methods Of Treatment For Solid Tumors
App 20130344138 - PURI; Kamal D. ;   et al.
2013-12-26
Methods of treatment for solid tumors
Grant 8,546,409 - Puri , et al. October 1, 2
2013-10-01
Compositions And Methods Of Treating A Proliferative Disease With A Quinazolinone Derivative
App 20130143902 - Evarts; Jerry B. ;   et al.
2013-06-06
Therapies For Hematologic Malignancies
App 20130071323 - Gallatin; W. Michael ;   et al.
2013-03-21
Combination Therapies For Hematologic Malignancies
App 20130064812 - GALLATIN; W. Michael ;   et al.
2013-03-14
Methods Of Treating Hematological Disorders With Quinazolinone Compounds In Selected Subjects
App 20110306622 - LANNUTTI; Brian ;   et al.
2011-12-15
Methods Of Treatment For Solid Tumors
App 20110044942 - PURI; Kamal D. ;   et al.
2011-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed